GL1X · GenesisL1 explorer

Research workbench

HCV NS5B polymerase in complex with 1,5 benzodiazepine inhibitor 4C

Analyse HCV NS5B polymerase in complex with 1,5 benzodiazepine inhibitor 4C in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3GNW
Type
protein
Length
1,128 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
RNA-directed RNA polymerase
EC
2.7.7.48
UniProt
O92972
Ligands
XNC, CL
Pockets
14 · best druggability 0.81

Structure

x-ray diffraction · 2 distinct chains · 49% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARNA-directed RNA polymerase (EC 2.7.7.48)protein56049% helix, 15% strandO92972
BRNA-directed RNA polymerase (EC 2.7.7.48)protein56849% helix, 16% strandO92972

Ligands and binding sites

  • XNC · (11S)-11-[4-(benzyloxy)-2-fluorophenyl]-3,3-dimethyl-10-[(6-methylpyridin-2-yl)carbonyl]-2,3,4,5,10,11-hexahydrothiopyrano[3,2-b][1,5]benzodiazepin-6-ol 1,1-dioxide · ligand · 2 copies · chains A, B
  • CL · Chloride ion · ion · 3 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

14 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110570.810.8287XNC, CL
210810.800.8281XNC, CL
39480.710.7683empty
41350.470.7719empty
51180.460.7919empty

Interfaces

1 interface between chains.

  • A–B · 408 Ų buried · 4 hydrogen bonds · protein-protein

Compared structures

  • 3GNW · HCV NS5B polymerase in complex with 1,5 benzodiazepine inhibitor 4c · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.